Ads
related to: treatment for hepatitis b carriers list of diseases and medications drugs- Hepatitis B Screening
Discover The Importance Of
Screening To Identify Hepatitis B
- Chronic Hep B Information
Understand Chronic Hep B & Find
Info On Screening For The Disease
- Mechanism Of Action
Learn More About The MOA Of A
Chronic Hep B Treatment Option
- Product Dosage Info
Find Dosage Information For A
Chronic Hep B Treatment Option
- CHB Patient Site
Visit The Official Website Designed
For Chronic Hep B Patients
- Patient Co-Pay Assistance
Discover A Program That May Help
Your Patients Pay For CHB Treatment
- Hepatitis B Screening
Search results
Results From The WOW.Com Content Network
hepatitis B surfage antigen: hepatitis B Lenzilumab [6] mab: human: CSF2: chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia: Lerdelimumab [17] mab: human: TGF-β2: reduction of scarring after glaucoma surgery: Leronlimab [5] mab: humanized: CCR5: breast cancer, HIV Lesofavumab [28] mab: human: Hemagglutinin (influenza ...
Hepatitis C Sofosbuvir: Hepatitis C [17] nucleoside analogue reverse transcriptase inhibitor: Stavudine: HIV Taribavirin (Viramidine) Hepatitis Syndromes in which Ribavirin is active [18] Telaprevir: Hepatitis C Telbivudine (Tyzeka) Hepatitis B: Tenofovir alafenamide: Hepatitis B: Tenofovir disoproxil: Hepatitis B, HIV [19] Tipranavir: HIV ...
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) that affects the liver; [1] [6] it is a type of viral hepatitis. [7] It can cause both acute and chronic infection. [1] Many people have no symptoms during an initial infection.
The DAA drugs against hepatitis C are taken orally, as tablets, for 8 to 12 weeks. [56] The treatment depends on the type or types of hepatitis C virus that are causing the infection. [57] Both during and at the end of treatment, blood tests are used to monitor the effectiveness of the treatment and subsequent cure. [56]
Lamivudine (Epivir) is indicated in combination with other antiretroviral agents for the treatment of HIV‑1 infection. [4] [6] Lamivudine (Epivir HBV) is indicated for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation.
Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (European Union) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance.
Acute hepatitis B; Acute hepatitis C; Acute hepatitis D – this is a superinfection with the delta-agent in a patient already infected with hepatitis B; Acute hepatitis E; Chronic viral hepatitis; Other viral hepatitis viruses may exist but their relation to the disease is not firmly established like the previous ones (hepatitis F, GB virus C ...
HBIG is indicated as a postexposure prophylaxis for people at risk to develop hepatitis B because they have been recently exposed to body fluids of individuals who have hepatitis B. This includes babies of mothers with hepatitis B, sexual partners, healthcare workers, police and fire workers, and morticians. [6]
Ad
related to: treatment for hepatitis b carriers list of diseases and medications drugs